Path Forward to Optimise Post-approval Change Management and Facilitate Continuous Supply of Medicines and Vaccines of High Quality Worldwide: Joint Position from EFPIA, IFPMA and Vaccines Europe

Post-approval changes (PACs) to the registered information of authorised medicinal products are introduced routinely worldwide to enhance the robustness and efficiency of the manufacturing process, ensure timely supply in case of increased demand, improve quality control techniques, respond to chang...

Descripción completa

Detalles Bibliográficos
Autores principales: Deavin, Andrew, Adam, Sarah, Ausborn, Susanne, Nielsen, Ane Sofie Böhm, Cappellini, Sonia, Colmagne-Poulard, Isabelle, Gastineau, Thierry, Gonzalez-Martinez, Arturo, Meillerais, Sylvie, Mortazavi, Charlie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345009/
https://www.ncbi.nlm.nih.gov/pubmed/35917091
http://dx.doi.org/10.1007/s43441-022-00426-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345009/
https://www.ncbi.nlm.nih.gov/pubmed/35917091
http://dx.doi.org/10.1007/s43441-022-00426-9

Ejemplares similares